+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gilead Sciences Inc - logo

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

Atopic Dermatitis Market Report 2025 - Product Thumbnail Image

Atopic Dermatitis Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Report 2022 - Product Thumbnail Image

Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Report 2022

  • Report
  • November 2022
  • 370 Pages
  • Global
From
Cancer Therapeutics Market: Emphasis on Recurrent and Metastatic Divisions - Product Thumbnail Image

Cancer Therapeutics Market: Emphasis on Recurrent and Metastatic Divisions

  • Report
  • March 2025
  • 211 Pages
  • Global
From
Oncologists Market Report 2025 - Product Thumbnail Image

Oncologists Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Antivirals Drug - Global Strategic Business Report - Product Thumbnail Image

Antivirals Drug - Global Strategic Business Report

  • Report
  • September 2025
  • 172 Pages
  • Global
From
Immunotherapy Drugs Market Size, Share & Trends by Type (mAb, Checkpoint Inhibitor, Interferon, Cancer Vaccine), Application (Cancer, Autoimmune, Inflammatory, Hematology, Neurology), Route of Administration (Intravenous, Subcutaneous), End User - Forecast to 2029 - Product Thumbnail Image

Immunotherapy Drugs Market Size, Share & Trends by Type (mAb, Checkpoint Inhibitor, Interferon, Cancer Vaccine), Application (Cancer, Autoimmune, Inflammatory, Hematology, Neurology), Route of Administration (Intravenous, Subcutaneous), End User - Forecast to 2029

  • Report
  • July 2024
  • 335 Pages
  • Global
From
Congestive Heart Failure Market - Global Forecast 2025-2030 - Product Thumbnail Image

Congestive Heart Failure Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 183 Pages
  • Global
From
Antiviral Drugs Market by Mechanism of Action, Target Indication, Type of Drug Target, Type of Therapy and Key Geographies: Industry Trends and Global Forecasts, 2022-2035 - Product Thumbnail Image

Antiviral Drugs Market by Mechanism of Action, Target Indication, Type of Drug Target, Type of Therapy and Key Geographies: Industry Trends and Global Forecasts, 2022-2035

  • Report
  • September 2022
  • 194 Pages
  • Global
From
Europe Pharmaceutical Market Size, Share & Trends Analysis Report By Molecule, By Product (Branded, Generics), By Type (Prescription, OTC), By Disease, By Age Group, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Thumbnail Image

Europe Pharmaceutical Market Size, Share & Trends Analysis Report By Molecule, By Product (Branded, Generics), By Type (Prescription, OTC), By Disease, By Age Group, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • June 2025
  • 250 Pages
  • Europe
From
West Nile Virus - Global Strategic Business Report - Product Thumbnail Image

West Nile Virus - Global Strategic Business Report

  • Report
  • September 2025
  • 169 Pages
  • Global
From
Bird Flu Treatment - Global Strategic Business Report - Product Thumbnail Image

Bird Flu Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 285 Pages
  • Global
From
Candidiasis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Candidiasis Therapeutics - Global Strategic Business Report

  • Report
  • September 2025
  • 474 Pages
  • Global
From
Cutaneous and Systemic Leishmaniasis - Global Strategic Business Report - Product Thumbnail Image

Cutaneous and Systemic Leishmaniasis - Global Strategic Business Report

  • Report
  • September 2025
  • 473 Pages
  • Global
From
Antifungal Drugs - Global Strategic Business Report - Product Thumbnail Image

Antifungal Drugs - Global Strategic Business Report

  • Report
  • September 2025
  • 179 Pages
  • Global
From
Oral Antivirals - Global Strategic Business Report - Product Thumbnail Image

Oral Antivirals - Global Strategic Business Report

  • Report
  • September 2025
  • 380 Pages
  • Global
From
Pseudomonas Aeruginosa Infection Treatment - Global Strategic Business Report - Product Thumbnail Image

Pseudomonas Aeruginosa Infection Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 273 Pages
  • Global
From
Neglected Tropical Disease Treatment - Global Strategic Business Report - Product Thumbnail Image

Neglected Tropical Disease Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 294 Pages
  • Global
From
Cytomegalovirus (CMV) Treatment - Global Strategic Business Report - Product Thumbnail Image

Cytomegalovirus (CMV) Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 384 Pages
  • Global
From
Anti-Infectives - Global Strategic Business Report - Product Thumbnail Image

Anti-Infectives - Global Strategic Business Report

  • Report
  • September 2025
  • 116 Pages
  • Global
From
Gene Editing Therapeutics Market - Product Thumbnail Image

Gene Editing Therapeutics Market

  • Report
  • August 2024
  • 111 Pages
  • Global
From
Loading Indicator